TRANSCEND CAPITAL ADVISORS, LLC SPDR S&P Biotech ETF Transaction History

TRANSCEND CAPITAL ADVISORS, LLC portfolio value:

$1.47M
portfolio value

TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:

+6.80%
quarter

SPDR S&P Biotech ETF 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +0.66% 122 shares 103K $79.32 18.64K
Q2 2022 share Increase +22.82% 3.44K shares 20K $74.27 18.52K
Q1 2022 share Decrease -0.82% -124 shares -347K $89.88 15.08K
Q4 2021 share Increase +207.52% 10.26K shares 1.09M $113.24 15.20K
Q3 2021 share Increase 0.00% 4.94K shares 613K $125.71 4.94K
Q2 2021 share Decrease -100.00% -6.26K shares -851K $135.4 0
Q1 2021 share Increase +0.53% 33 shares -26K $135.65 6.26K
Q4 2020 share Decrease -18.75% -1.43K shares 22K $140.74 6.23K
Q3 2020 share Increase 0.00% 7.67K shares 855K $111.27 7.67K